Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of PolyPid's Doxycycline hyclate CR?
Doxycycline hyclate CR is a small molecule commercialized by PolyPid, with a leading Phase III program in Surgical Wound Infections....
Data Insights
Risk adjusted net present value: What is the current valuation of PolyPid's Doxycycline hyclate CR?
Doxycycline hyclate CR is a small molecule commercialized by PolyPid, with a leading Phase III program in Surgical Wound Infections....